aldosterone has been researched along with Systolic Heart Failure in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "In EMPHASIS-HF, eplerenone improved outcomes in HFrEF patients with and without abdominal obesity, although the benefit appeared to be more pronounced among those with abdominal obesity." | 9.24 | Effect of eplerenone in patients with heart failure and reduced ejection fraction: potential effect modification by abdominal obesity. Insight from the EMPHASIS-HF trial. ( Collier, TJ; Girerd, N; Lamiral, Z; Machu, JL; McMurray, JJV; Olivier, A; Pitt, B; Pizard, A; Pocock, SJ; Rossignol, P; Swedberg, K; van Veldhuisen, DJ; Zannad, F, 2017) |
| "In EMPHASIS-HF, eplerenone improved outcomes in HFrEF patients with and without abdominal obesity, although the benefit appeared to be more pronounced among those with abdominal obesity." | 5.24 | Effect of eplerenone in patients with heart failure and reduced ejection fraction: potential effect modification by abdominal obesity. Insight from the EMPHASIS-HF trial. ( Collier, TJ; Girerd, N; Lamiral, Z; Machu, JL; McMurray, JJV; Olivier, A; Pitt, B; Pizard, A; Pocock, SJ; Rossignol, P; Swedberg, K; van Veldhuisen, DJ; Zannad, F, 2017) |
| "Systolic heart failure is a feed-forward phenomenon with devastating consequences." | 2.45 | Pharmacological treatment for heart failure: a view from the brain. ( Felder, RB; Wei, SG; Yu, Y; Zhang, ZH, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maron, BA | 1 |
| Stephens, TE | 1 |
| Farrell, LA | 1 |
| Oldham, WM | 1 |
| Loscalzo, J | 1 |
| Leopold, JA | 1 |
| Lewis, GD | 1 |
| Olivier, A | 1 |
| Pitt, B | 1 |
| Girerd, N | 1 |
| Lamiral, Z | 1 |
| Machu, JL | 1 |
| McMurray, JJV | 1 |
| Swedberg, K | 1 |
| van Veldhuisen, DJ | 1 |
| Collier, TJ | 1 |
| Pocock, SJ | 1 |
| Rossignol, P | 1 |
| Zannad, F | 1 |
| Pizard, A | 1 |
| Felder, RB | 1 |
| Yu, Y | 1 |
| Zhang, ZH | 1 |
| Wei, SG | 1 |
1 review available for aldosterone and Systolic Heart Failure
| Article | Year |
|---|---|
Pharmacological treatment for heart failure: a view from the brain.
Topics: Aldosterone; Angiotensins; Animals; Blood-Brain Barrier; Brain; Cardiovascular Agents; Cell Communic | 2009 |
1 trial available for aldosterone and Systolic Heart Failure
| Article | Year |
|---|---|
Effect of eplerenone in patients with heart failure and reduced ejection fraction: potential effect modification by abdominal obesity. Insight from the EMPHASIS-HF trial.
Topics: Aged; Aldosterone; Drug Monitoring; Eplerenone; Female; Heart Failure, Systolic; Humans; Male; Middl | 2017 |
1 other study available for aldosterone and Systolic Heart Failure
| Article | Year |
|---|---|
Elevated pulmonary arterial and systemic plasma aldosterone levels associate with impaired cardiac reserve capacity during exercise in left ventricular systolic heart failure patients: A pilot study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aldosterone; Endothelin-1; Exercise; Female; Fractional | 2016 |